An international team led by researchers at the Institute of Cosmos Sciences of the University of Barcelona (ICCUB) has ...
Objectives While exercise adherence is known to vary during cancer treatment, little is known about what predicts these changes during chemotherapy or within individual treatment cycles for breast ...
Johnson & Johnson today announced findings from the first network meta-analysis (NMA) comparing CAPLYTA® (lumateperone) to FDA-approved atypical antipsychotics for add-on treatment of major depressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results